Laird Superfood, Inc. (LSF)
NYSEAMERICAN: LSF · Real-Time Price · USD
6.36
-0.78 (-10.92%)
Aug 7, 2025, 12:59 PM - Market open
Sage Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$12.00
Upside
+88.68%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +88.68% | Jun 30, 2025 |
Roth MKM | Roth MKM | Strong Buy Reiterates $8 → $12 | Strong Buy | Reiterates | $8 → $12 | +88.68% | Nov 7, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $4.5 → $6 | Strong Buy | Reiterates | $4.5 → $6 | -5.66% | Aug 8, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $2.5 → $3.5 | Strong Buy | Maintains | $2.5 → $3.5 | -44.97% | May 9, 2024 |
Roth MKM | Roth MKM | Hold → Strong Buy Upgrades $1.3 → $4.5 | Hold → Strong Buy | Upgrades | $1.3 → $4.5 | -29.25% | May 9, 2024 |
Roth MKM | Roth MKM | Hold Reiterates $0.85 → $1.3 | Hold | Reiterates | $0.85 → $1.3 | -79.56% | Mar 13, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $12 | Strong Buy | Maintains | $17 → $12 | +88.68% | Mar 9, 2022 |
Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $42 → $23 | Strong Buy → Hold | Downgrades | $42 → $23 | +261.64% | Aug 12, 2021 |
Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +796.23% | Oct 19, 2020 |